Celestial Biolabs Ltd
Celestial Biolabs is engaged in activities of manufacturingof Ayurvedic products and Trading of Feed suppliments.
- Market Cap ₹ 3.95 Cr.
- Current Price ₹ 1.75
- High / Low ₹ /
- Stock P/E
- Book Value ₹ 1.17
- Dividend Yield 0.00 %
- ROCE -3.84 %
- ROE -18.9 %
- Face Value ₹ 10.0
Pros
Cons
- Company has low interest coverage ratio.
- Promoter holding is low: 26.1%
- Contingent liabilities of Rs.1.29 Cr.
- Company might be capitalizing the interest cost
- Company has high debtors of 7,966 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | TTM | |
|---|---|---|---|
| 0.15 | 0.17 | 0.14 | |
| 0.49 | 0.71 | 0.52 | |
| Operating Profit | -0.34 | -0.54 | -0.38 |
| OPM % | -226.67% | -317.65% | -271.43% |
| 0.00 | 0.00 | 0.00 | |
| Interest | 0.04 | 0.01 | 0.01 |
| Depreciation | 0.03 | 0.03 | 0.04 |
| Profit before tax | -0.41 | -0.58 | -0.43 |
| Tax % | 0.00% | 0.00% | |
| -0.41 | -0.58 | -0.41 | |
| EPS in Rs | -0.18 | -0.26 | -0.18 |
| Dividend Payout % | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -26% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 33% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -26% |
| 5 Years: | -11% |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | -19% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Sep 2023 | |
|---|---|---|---|
| Equity Capital | 22.59 | 22.59 | 22.59 |
| Reserves | -19.24 | -19.81 | -19.94 |
| 11.54 | 12.03 | 12.04 | |
| 2.29 | 2.43 | 2.49 | |
| Total Liabilities | 17.18 | 17.24 | 17.18 |
| 0.10 | 0.08 | 0.06 | |
| CWIP | 12.82 | 12.82 | 12.82 |
| Investments | 0.00 | 0.00 | 0.00 |
| 4.26 | 4.34 | 4.30 | |
| Total Assets | 17.18 | 17.24 | 17.18 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | |
|---|---|---|
| -0.28 | -0.36 | |
| 0.00 | 0.00 | |
| 0.26 | 0.38 | |
| Net Cash Flow | -0.02 | 0.02 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | |
|---|---|---|
| Debtor Days | 9,319.67 | 7,965.59 |
| Inventory Days | 86.90 | 99.55 |
| Days Payable | 451.90 | 1,161.36 |
| Cash Conversion Cycle | 8,954.67 | 6,903.77 |
| Working Capital Days | 4,793.67 | 4,036.47 |
| ROCE % | -3.84% |
Documents
Annual reports
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2013
from nse
-
Financial Year 2012
from bse
-
Financial Year 2011
from nse
-
Financial Year 2010
from bse
-
Financial Year 2010
from nse